This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Barthez, M.-A. Articles by Donadieu, J. Search for Related Content PubMed PubMed Citation Articles by Barthez, M.-A. Articles by Donadieu, J. Pubmed/NCBI databases Medline Plus Health Information Brain Diseases Social Bookmarking                   What's this?

Langerhans Cell Histiocytosis and the Central Nervous System in Childhood: Evolution and Prognostic Factors. Results of a Collaborative Study

Unité de Neurologie Pédiatrique, Hôpital Gatien de Clocheville, cath.billard2{at}wanadoo.fr

Elizabeth Araujo, MD

Unité de Neurologie Pédiatrique, Hôpital Gatien de Clocheville

Jean Donadieu, MD

CHU Tours, and the Service d'Hématologie-Oncologie Pédiatrique, Hôpital Trousseau Paris

This retrospective study detailed clinical and radiologic involvement of the central nervous system related to Langerhans cell histiocytosis in 18 French children. We excluded cases of isolated hypothalamic-pituitary dysfunction or spinal involvement. Cerebellar symptoms were the most common clinical symptoms. Two different patterns of magnetic resonance or computed tomographic images were identified: demyelination and gliosis or atrophy, described as degenerative lesions, mostly located in the cerebellum in 10 children, or tumor-like lesions occurring in any part of the brain in 13 children. Six children had both types of lesion. The clinical cerebellar syndrome correlated with the specific imaging pattern suggestive of a cerebellar degenerative lesion, which did not show any changes after treatment. As suggested by this study and previous clinical and histologic reports, it is believed that brain involvement in the course of Langerhans cell histiocytosis might arise from different disease mechanisms: primary histiocyte proliferation and secondary atrophy or demyelination and gliosis of unknown origin. Treatment consequently should be adapted to the supposed mechanism of the lesion. (J Child Neurol 2000;15:150-156).

Journal of Child Neurology, Vol. 15, No. 3, 150-156 (2000)
DOI: 10.1177/088307380001500302


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. S. van der Knaap, W.F.M. Arts, J. Y. Garbern, G. Hedlund, F. Winkler, C. Barbosa, M. D. King, A. Bjornstad, N. Hussain, M. K. Beyer, et al. Cerebellar leukoencephalopathy: Most likely histiocytosis-related Neurology, October 21, 2008; 71(17): 1361 - 1367. [Abstract] [Full Text] [PDF]

				S. Imashuku, Y. Shioda, R. Kobayashi, G. Hosoi, H. Fujino, S. Seto, H. Wakita, A. Oka, N. Okazaki, N. Fujita, et al. Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH Study Group Haematologica, April 1, 2008; 93(4): 615 - 618. [Abstract] [Full Text] [PDF]

				H. Prosch, N. Grois, M. Wnorowski, M. Steiner, and D. Prayer Long-Term MR Imaging Course of Neurodegenerative Langerhans Cell Histiocytosis AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1022 - 1028. [Abstract] [Full Text] [PDF]

				J. S. Hahn, D. Pohl, M. Rensel, S. Rao, and for the International Pediatric MS Study Group Differential diagnosis and evaluation in pediatric multiple sclerosis Neurology, April 17, 2007; 68(16_suppl_2): S13 - S22. [Abstract] [Full Text] [PDF]

				N. Grois, D. Prayer, H. Prosch, H. Lassmann, and the CNS LCH Co-operative Group Neuropathology of CNS disease in Langerhans cell histiocytosis Brain, April 1, 2005; 128(4): 829 - 838. [Abstract] [Full Text] [PDF]

				M. Steiner, D. Prayer, S. Asenbaum, H. Prosch, M. Minkov, E. Unger, and N. Grois Modern Imaging Methods for the Assessment of Langerhans' Cell Histiocytosis--Associated Neurodegenerative Syndrome: Case Report J Child Neurol, March 1, 2005; 20(3): 253 - 257. [Abstract] [PDF]

				D. Prayer, N. Grois, H. Prosch, H. Gadner, and A. J. Barkovich MR Imaging Presentation of Intracranial Disease Associated with Langerhans Cell Histiocytosis AJNR Am. J. Neuroradiol., May 1, 2004; 25(5): 880 - 891. [Abstract] [Full Text] [PDF]

				J. Donadieu, M.-A. Rolon, I. Pion, C. Thomas, F. Doz, M. Barkaoui, A. Robert, A. Deville, F. Mazingue, M. David, et al. Incidence of Growth Hormone Deficiency in Pediatric-Onset Langerhans Cell Histiocytosis: Efficacy and Safety of Growth Hormone Treatment J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 604 - 609. [Abstract] [Full Text] [PDF]

				A. A. Jarquin-Valdivia and J. Buchhalter Delayed Diagnosis of Pediatric Langerhans' Cell Histiocytosis: Case Report and Retrospective Review of Pediatric Cases Seen at Mayo Clinic J Child Neurol, July 1, 2001; 16(7): 535 - 538. [Abstract] [PDF]